cagrilintide third party tested CAG (CAGRILINTIDE) 5MG Retatrutide Cagrilintide Blend Peptide |
Description
This is encouraging, though the sample size is too small for definitive safety conclusions

Russell, R

no claimed effects in humans

Use of the cumulative proportion of responders analysis graph to present pain data over a range of cut-off points: making clinical trial data more understandable

M.et al (2021)

Pumping between phases with a pulsed-fuel molecular ratchet
